Allogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients
Overall survival 64 and 55 percent at one and two years; nonrelapse mortality 20 and 28 percent, respectively
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.